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Background
In the past ten years an effort has been made to establish
clinical criteria, in order to predict which individuals are
at ultra high risk (UHR) of developing psychosis. Various
preventive and therapeutic methods have been used at
people with incipient risk of developing psychosis, psy-
chotherapeutic as well as psychopharmacological. The
psychotherapeutic techniques are certainly more appro-
priate to use in such populations for safety reasons. The
goal of our presentation is to find out if there has been suf-
ficient indication of the efficacy of such psychotherapeutic
techniques through randomized control trials.
Materials and methods
We conducted a systematic literature search through the
web, for the years 1980-2007, combining key words of
“prevention”, “ultra high risk”, “prodrome”, “psychosis”,
“psychotherapy” and then limited our results to “ran-
domised control trials”. We also searched for major meta-
analyses and reviews of prevention studies for psychosis.
Results
Only two randomised control studies were found to be
conducted in such populations, searching for the efficacy
of cognitive therapy and needs-based supportive psycho-
therapy.
Conclusions
Both of them demonstrated that psychotherapy is useful
in such groups, since it reduces the likelihood of making
progression to psychosis, the need for prescription of
antipsychotic medication and has enduring benefits over
the long term.
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